+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Insulin Delivery Devices Market 2019-2025

  • ID: 4863379
  • Report
  • October 2019
  • Region: Global
  • Orion Market Research Private Limited

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Becton, Dickinson and Co.
  • Eli Lilly and Co.
  • Insulet Corp.
  • Medtronic PLC
  • SciGen Pte Ltd.
Global Insulin Delivery Devices Market Size, Share & Trends Analysis Report, By Type (Insulin Syringes, Insulin Pens, Insulin Jet Injectors, and Insulin Pumps), By End-User (Hospitals & Clinics and Homecare), and Forecast 2019-2025.

The global insulin delivery devices market is anticipated to grow at a significant rate. Increasing diabetes incidences and rapidly growing obese population are anticipated to drive the market growth. Furthermore, the propagation of diabetes management awareness programs by government impetus to fuel the growth of the insulin delivery devices market across the globe. However, the high cost of insulin pumps, insurance coverage issues, regulatory pressure and technological issues involved in insulin delivery devices are the major restraints for the growth of this market.

The global insulin delivery devices market is categorized on the basis of type and end-user. Based on the end-user, the homecare usage segment held the major market share in 2018. Based on type, the market is segmented into insulin pen, insulin pump, insulin syringes, and insulin jet injectors. Among these devices, insulin pen is expected to hold a prominent market share. The global insulin delivery devices market is further segmented on the basis of geography including North America, Europe, Asia-Pacific and Rest of the World. North America held the largest market share in 2018. The growing diabetic population and accessibility of technically advanced devices are anticipated to drive the growth of the market in North America. Asia-Pacific is projected to register high growth during the forecast period.

Some of the key players operating in the market include Novo Nordisk A/S, Eli Lilly and Co., Sanofi SA, Becton, Dickinson, and Co., Medtronic PLC, Valeritas Holdings, Inc., and others. The key players of the market are constantly striving to introduce new, innovative and superior product launches to gain a competitive edge over other competitors. Further, the players are collaborating with other firms in order to enhance their foothold in the market. For instance, in November 2018, Valeritas Holdings, Inc. signed an agreement with Julphar, for the commercialization of its V-Go Wearable Insulin Delivery Device in the GCC (Gulf Cooperation Council). With this agreement, the company has V-Go distribution agreements in place covering 14 countries and territories. In addition, the company has started the process to gain regulatory approval for V-Go in China.

Research Methodology

The market study of the global insulin delivery devices market is incorporated by extensive primary and secondary research . Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. the research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Authenticate databases such as the National Institute of Health, CDC, and IDF.
  • Company websites and their product catalog.

The report is intended for insulin pens manufacturers, insulin pump manufacturers, insulin jet injector manufacturers, insulin syringe manufacturers, medical device companies, supplier, traders, and third-party distributor, contract manufacturers, healthcare organizations and research institutes, government organizations and regulatory agencies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. Global Insulin Delivery Devices Market Research and Analysis by Type.

2. Global Insulin Delivery Devices Market Research and Analysis by End-User.

The Report Covers
  • Comprehensive research methodology of the global insulin delivery devices market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global insulin delivery devices market.
  • Insights about market determinants which are stimulating the global insulin delivery devices market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Becton, Dickinson and Co.
  • Eli Lilly and Co.
  • Insulet Corp.
  • Medtronic PLC
  • SciGen Pte Ltd.

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Novo Nordisk A/S
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Development
3.3.2. Eli Lilly and Co.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Sanofi SA
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Becton Dickinson, and Co.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Medtronic PLC
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Insulin Delivery Devices Market by Type
5.1.1. Insulin Syringes
5.1.2. Insulin Pens
5.1.3. Insulin Jet Injectors
5.1.4. Insulin Pumps
5.2. Global Insulin Delivery Devices Market by End-User
5.2.1. Hospitals & Clinics
5.2.2. Homecare
6. Regional Analysis
6.1. North America
6.1.1. US
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Animas LLC
7.2. Abbott Laboratories, Inc.
7.3. B. Braun Melsungen AG
7.4. Becton, Dickinson and Co.
7.5. Bigfoot Biomedical Inc.
7.6. Biocon Ltd.
7.7. Eli Lilly and Co.
7.8. F. Hoffmann-La Roche AG
7.9. Gerresheimer AG
7.10. Insulet Corp.
7.11. Julphar
7.12. MannKind Corp.
7.13. Medtronic PLC
7.14. Novo Nordisk A/S
7.15. Sanofi SA
7.16. SciGen Pte Ltd.
7.17. Tandem Diabetes Care, Inc.
7.18. Valeritas Holdings, Inc.
7.19. Wockhardt Ltd.
7.20. Ypsomed AG
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Animas LLC
  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Co.
  • Bigfoot Biomedical Inc.
  • Biocon Ltd.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche AG
  • Gerresheimer AG
  • Insulet Corp.
  • Julphar
  • MannKind Corp.
  • Medtronic PLC
  • Novo Nordisk A/S
  • Sanofi SA
  • SciGen Pte Ltd.
  • Tandem Diabetes Care, Inc.
  • Valeritas Holdings, Inc.
  • Wockhardt Ltd.
  • Ypsomed AG
Note: Product cover images may vary from those shown